CabaĆero, Melanie O.
HRN: 12-99-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2025
CEFTRIAXONE 1G (VIAL)
03/27/2025
04/02/2025
IVT
1g
Q12
Typhoid UTI
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes